GB Meka
Stocks to watch

BBIO

Compare

BRIDGEBIO PHARMA INC · Healthcare

$67.19
▲ 1.9%Close 2026-09-30

Live intraday price

Compare with our price levels

T271.74
T169.74
E162.70
E352.75
SL50.02

Close 2026-09-30: $67.19 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting• Neutral

Not in the buy zone yet — needs to drop 6.7% · 1 whale recently bought

1 month
▼ 12.3%
3 months
▼ 9.8%
1 year
▲ 29.3%
Analyst target
$109.10 +62.4%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$62.70 -6.7%
E2$60.22 -10.4%
E3$52.75 -21.5%
Targets
T1$69.74 3.8%
T2$71.74 6.8%
T3$73.70 9.7%
Stop-loss
SL$50.02 -25.6%
Whale cost ~$70.54 5.0%

Risk : reward 1 : 1.5Moves ~$2.73 a day

⚖️ Positives and risks

✓ Positives (5)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
  • ●MACD เพิ่งตัดขึ้น (โมเมนตัมเริ่มกลับเป็นบวก)
  • ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 109.10 (upside +62%, 21 ราย)
  • ●นักวิเคราะห์ส่วนใหญ่แนะนำ Strong Buy
  • ●รายได้โต +120% เทียบปีก่อน
! Risks (5)
  • ●เซียนขายออก/ลดสัดส่วน 1 ราย: Andreas Halvorsen (ลด)
  • ●แนวโน้มระยะยาวเป็นขาลง (ใต้ MA200 และ MA200 ชี้ลง)
  • ●อ่อนแอกว่าตลาด (S&P 500) -28% ใน 6 เดือน
  • ●บริษัทยังขาดทุน (อัตรากำไรสุทธิติดลบ)
  • ●Forward P/E สูง 2387 เท่า (คาดหวังการเติบโตไว้มาก)

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

Kumar Neil · CEO · Director

2026-09-17 · 8,721 shares @ $69.01 · pre-planned sale (10b5-1)

$601,868
Sell

Kumar Neil · CEO · Director

2026-09-17 · 1,279 shares @ $69.57 · pre-planned sale (10b5-1)

$88,980
Sell

Kumar Neil · CEO · Director

2026-08-19 · 8,100 shares @ $83.86 · pre-planned sale (10b5-1)

$679,256
Sell

Kumar Neil · CEO · Director

2026-08-19 · 1,800 shares @ $84.69 · pre-planned sale (10b5-1)

$152,436
Sell

Kumar Neil · CEO · Director

2026-08-19 · 100 shares @ $85.65 · pre-planned sale (10b5-1)

$8,565
Sell

Kumar Neil · CEO · Director

2026-08-18 · 17,279 shares @ $82.21 · pre-planned sale (10b5-1)

$1M
Sell

Kumar Neil · CEO · Director

2026-08-18 · 14,602 shares @ $82.99 · pre-planned sale (10b5-1)

$1M
Sell

Kumar Neil · CEO · Director

2026-08-18 · 1,900 shares @ $81.15 · pre-planned sale (10b5-1)

$154,184
Sell

Kumar Neil · CEO · Director

2026-08-18 · 1,199 shares @ $83.77 · pre-planned sale (10b5-1)

$100,444
Sell

Apuli Maricel · Officer

2026-07-30 · 2,000 shares @ $80.06 · pre-planned sale (10b5-1)

$160,120
Sell

Cook Jennifer E. · Director

2026-07-09 · 112,422 shares @ $90.00 · pre-planned sale (10b5-1)

$10M
Sell

Cook Jennifer E. · Director

2026-07-09 · 36,167 shares @ $84.00 · pre-planned sale (10b5-1)

$3M
Sell

Ellis Andrea · Director

2026-07-09 · 17,167 shares @ $84.00 · pre-planned sale (10b5-1)

$1M
Sell

Cook Jennifer E. · Director

2026-06-24 · 37,167 shares @ $70.00 · pre-planned sale (10b5-1)

$3M
Sell

Valantine Hannah · Director

2026-06-23 · 2,196 shares @ $68.57 · pre-planned sale (10b5-1)

$150,580

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-08-10Miss -34%

Actual EPS -$0.78 · est. -$0.58 · After close

▼ 1.1%

Day 1

-9.1%

Next 20 days

2026-05-07Miss -36%

Actual EPS -$0.84 · est. -$0.62 · After close

▼ 0.1%

Day 1

-0.0%

Next 20 days

2026-02-24Miss -51%

Actual EPS -$0.94 · est. -$0.62 · After close

▼ 2.6%

Day 1

+7.6%

Next 20 days

2025-10-29Beat +8%

Actual EPS -$0.72 · est. -$0.78 · After close

▼ 4.9%

Day 1

+13.6%

Next 20 days

2025-08-05Miss -57%

Actual EPS -$0.95 · est. -$0.60 · After close

▼ 8.9%

Day 1

+15.7%

Next 20 days

2025-04-29In line +1%

Actual EPS -$0.99 · est. -$1.00 · After close

▲ 5.3%

Day 1

-13.0%

Next 20 days

2025-02-20Miss -26%

Actual EPS -$1.37 · est. -$1.09 · Before open

▲ 1.4%

Day 1

-7.9%

Next 20 days

2024-11-12Miss -25%

Actual EPS -$1.08 · est. -$0.86 · Before open

▼ 5.7%

Day 1

+17.7%

Next 20 days

Listen to the earnings call or read the full report on BBIO's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$12.8B
Next earnings2026-10-28
P/E (price to earnings)-
Forward P/E (on expected earnings)2387.0
Revenue growth (YoY)+120.4%
Earnings growth (YoY)-
Net profit margin-97.0%
ROE-
Debt to equity (D/E)-
Dividend yield-
Analyst targets (high / low)$157.00 / $80.00
Number of analysts21
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Downtrend ↘ · Downtrend ↘
RSI37
MA50 / MA200$76.98 / $73.66
Distance from MA200-8.8%
MACDJust crossed up
1-year high / low$93.42 / $50.80
vs. S&P 500 (6 months)-28.2%
Volume vs. average0.21×